Sugi Predict

Sugi Predict / Compounds / SCHEMBL831073

SCHEMBL831073

SCHEMBL831073

O=Cc1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O

nearest known ligand 0.71

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ERN1 O75460 12/20 0.67
▸ GPR35 Q9HC97 4/20 0.61
▸ ALDH1A1 P00352 2/20 0.61
▸ KDM4E B2RXH2 1/20 0.61
▸ MEN1 O00255 1/20 0.61
▸ TTR P02766 1/20 0.61
▸ CYP1A2 P05177 1/20 0.61
▸ MAPT P10636 1/20 0.61
▸ CYP2C9 P11712 1/20 0.61
▸ HPGD P15428 1/20 0.61
▸ ALOX15 P16050 1/20 0.61
▸ ALOX12 P18054 1/20 0.61
▸ MAPK1 P28482 1/20 0.61
▸ RECQL P46063 1/20 0.61
▸ PMP22 Q01453 1/20 0.61
▸ KMT2A Q03164 1/20 0.61
▸ HIF1A Q16665 1/20 0.61
▸ HSD17B10 Q99714 1/20 0.61
▸ TDP1 Q9NUW8 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29441809 1.00 ERN1 (0.67) ERN1GPR35ALDH1A1KDM4EMEN1
SCHEMBL12492120 0.88 ERN1 (0.69) ERN1GPR35ALDH1A1KDM4EMEN1
SCHEMBL7169587 0.84 GPR35 (0.59) ERN1GPR35ALDH1A1KDM4EMEN1
SCHEMBL4756022 0.83 ERN1 (0.63) ERN1GPR35ALDH1A1KDM4EMEN1
SCHEMBL7172702 0.82 GPR35 (0.58) ERN1GPR35ALDH1A1KDM4EMEN1
Trinitrophenol SCHEMBL8744 0.82 GPR35 (0.79) GPR35ALDH1A1KDM4EMEN1TTR
Trinitrophenol SCHEMBL253750 0.82 GPR35 (0.79) GPR35ALDH1A1KDM4EMEN1TTR
SCHEMBL15783651 0.81 XDH (0.71) ERN1
Trinitrophenol SCHEMBL10635686 0.81 GPR35 (0.67) ERN1GPR35ALDH1A1KDM4EMEN1
Trinitrophenol SCHEMBL10799529 0.81 GPR35 (0.66) ERN1GPR35ALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 253 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250333373-A1 L-2-Amino-4-Halobutyric Acid Derivative-L-Tartrate and Preparation Method Thereof Vulpes Agricultural Corp. (US) 2025-10-30 — — US claimed
US-20240270768-A1 A METHOD FOR OBTAINING L-GLUFOSINATE UPL LTD (IN) 2024-08-15 — — US claimed
CN-117821019-A Reversible thermochromic solid-solid phase change material and preparation method thereof 四川大学 2024-04-05 — — CN claimed
CN-117597026-A Method for obtaining L-glufosinate UPL有限公司 2024-02-23 — — CN claimed
WO-2023230041-A2 L-2-AMINO-4-HALOBUTYRIC ACID DERIVATIVE-L-TARTRATE AND PREPARATION METHOD THEREOF Vulpes Agricultural Corp. (US) 2023-11-30 — — WO claimed
WO-2022259267-A1 A METHOD FOR OBTAINING L-GLUFOSINATE UPL LIMITED (IN) 2022-12-15 — — WO claimed
CN-111909979-A Preparation method of L-glufosinate-ammonium 武汉英凯生物技术研究院有限公司 2020-11-10 — — CN claimed
EP-2245132-B1 ENCAPSULATED BENEFIT AGENT UNILEVER PLC NO 41424 (GB) 2017-10-18 — — EP claimed
WO-2015191640-A2 BICYCLIC XANTHINE OXIDASE INHIBITORS AND METHODS OF USE BAYLOR COLLEGE OF MEDICINE (US) 2015-12-17 — — WO claimed
WO-2015191636-A2 XANTHINE OXIDASE INHIBITORS AND METHODS OF USE BAYLOR COLLEGE OF MEDICINE (US) 2015-12-17 — — WO claimed
EP-1300132-A2 Agent for dyeing keratinous fibres Henkel Kommanditgesellschaft auf Aktien (DE) 2003-04-09 — — EP claimed
CN-1328879-A Preparation method of self-solidified 'after cyclopentadiene' nickel base olefinic polymerization catalyst CHANGCHUN APPLIED CHEMISTRY (CN) 2002-01-02 — — CN claimed
EP-0562877-B1 Cell fixative and method of staining cells without destroying the cell surface ORTHO DIAGNOSTIC SYSTEMS INC (US) 2000-06-14 — — EP claimed
EP-0748325-B1 PROCESS FOR PREPARING [L]- OR [D]-HOMOALANIN-4-YL-(METHYL)PHOSPHINIC ACID AND ITS SALTS BY RACEMIC RESOLUTION HOECHST SCHERING AGREVO GMBH (DE) 1999-02-03 — — EP claimed
WO-1998059016-A1 COMPOSITION AND METHOD FOR INHIBITING RADICAL POLYMERISATION OF ETHYLENICALLY UNSATURATED AROMATIC MONOMERS RHODIA CHIMIE (FR) 1998-12-30 — — WO claimed
US-5767309-A PRECIPITATION OF ONE DISTEREOISOMERS HOECHST SCHERING AGREVO GMBH (DE) 1998-06-16 — — US claimed
EP-0748325-A1 PROCESS FOR PREPARING [L]- OR [D]-HOMOALANIN-4-YL-(METHYL)PHOSPHINIC ACID AND ITS SALTS BY RACEMIC RESOLUTION Hoechst Schering AgrEvo GmbH (DE) 1996-12-18 — — EP claimed
WO-1995023805-A1 PROCESS FOR PREPARING [L]- OR [D]-HOMOALANIN-4-YL-(METHYL)PHOSPHINIC ACID AND ITS SALTS BY RACEMIC RESOLUTION HOECHST SCHERING AGREVO GMBH (DE) 1995-09-08 — — WO claimed
US-5422277-A Compound for preserving intracellular morphology, compound for fixing internal components of cell, compound which facilitates transport of components across cell membranes, compound for increasing permeability of membranes ORTHO DIAGNOSTIC SYSTEMS INC. (US) 1995-06-06 — — US claimed
EP-0562877-A2 Cell fixative and method of staining cells without destroying the cell surface ORTHO DIAGNOSTIC SYSTEMS INC. (a New Jersey corp.) (US) 1993-09-29 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250333373-A1 L-2-Amino-4-Halobutyric Acid Derivative-L-Tartrate and Preparation Method Thereof DDC, ALAD, LDHB ERN1 3591/4885GPR35 2765/4885ALDH1A1 337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.